Clinical Trial Update: Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System

View source ↗

Summary

The clinical trial evaluating the combined use of Apligraf and the SNaP Pressure Wound Therapy System for diabetic foot ulcers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Apligraf
• SNaP Pressure Wound Therapy System

Snippet

Sponsor: KCI USA, Inc | Conditions: Diabetic Foot Ulcer | Status: WITHDRAWN